Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

ARCTARCT
Showing 8 of 25 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in ARCTURUS THERAPEUTICS HLDGS

BNP PARIBAS FINANCIAL MARKETS holds 261,789 shares of ARCT (ARCTURUS THERAPEUTICS HLDGS), worth $1.8M as of 2026-Q2. The position was increased (+34.4% shares). ARCT represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.

Current Value

$1.8M

Current Shares

261,789

Total Value Change

+$1.4M

Total Shares Change

+245,958

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
261,789
+34.4%
$1.8M0.0%$6.72
33
2026-Q1
Increased
194,860
+32.8%
$1.5M0.0%$7.91
33
2025-Q4
Increased
146,767
+2043.2%
$899,6820.0%$6.19
40
2025-Q3
Increased
6,848
+64.3%
$126,2090.0%$18.78
32
2025-Q2
Increased
4,169
+163.4%
$54,2390.0%$13.33
23
2025-Q1
Decreased
1,583
-42.2%
$16,7640.0%$11.58
0
2024-Q4
Decreased
2,738
-82.7%
$46,4640.0%$16.58
0
2024-Q3
Increased
15,831
+954.7%
$367,4380.0%$22.03
38

Other major holders of ARCT: ARK Investment Management LLC, FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used